Gamma-Secretase as a Pharmacological Target in Alzheimer Disease Research: When, Why and How?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|33|4313-4335

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.33, 2006-11, pp. : 4313-4335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

&ggr;-Secretase as a Target for Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 4, 2002-04 ,pp. : 371-383

Bentham Science Publishers

Access to resources Recommend Favorite

&ggr;-Secretase as a Therapeutic Target for Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 661-670

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Management of Alzheimer's Disease

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 33, Iss. 1, 2003-03 ,pp. : 24-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human β-secretase and Alzheimer’s disease

By Citron Martin  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 3, 2001-06 ,pp. : 341-348

Informa Healthcare

Access to resources Recommend Favorite

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 1, 2017-02 ,pp. : 3-25

Bentham Science Publishers

Access to resources Recommend Favorite